$VICR

VINCIARELLI PATRIZIO sold $234K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 700 shares of VICOR CORP (VICR) at $334.31 ($0.23M total) on 2026-05-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published May 29, 2026, 6:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 7:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
high confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

Because the transaction is pre-planned, it is generally less informative about near-term business outlook; the main tradable element is potential short-term sentiment/positioning impact.

02

Market read

Traders may monitor for patterns of repeated insider activity, but this single 10b5-1 sale is unlikely to reset valuation expectations.

03

What to watch

The sale size ($234k) is modest relative to typical institutional flows; without additional context (e.g., multiple consecutive sales), signal strength is limited.

Relevance 6/10Novelty 3/10Timing: Filed May 29, 2026 (covering a May 28 sale)

Background

This is an SEC Form 4 insider transaction for Vicor Corp, showing an open-market sale by the chairman/CEO under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralHigh confidence
Context

VICR’s CEO/chairman sold 700 shares in an open-market transaction disclosed via SEC Form 4 on May 29, 2026.

Expected impact

Likely limited immediate price impact; any reaction is more sentiment/flow-driven than fundamental.

Evidence & confidence

The filing is an insider transaction (Form 4) with an explicitly pre-arranged Rule 10b5-1 plan, reducing interpretive value versus discretionary selling.

Market effects

Minimal—single-company insider sale with no stated operational/regulatory catalyst.

None indicated.

None indicated.

Counterpoint

If the market treats insider sales as bearish regardless of 10b5-1, the stock could see short-lived selling pressure or options demand shifts.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider sale disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO / officer-director-10% owner who sold shares.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: